Active Development

Reset

Delivery Type

Reset

Duration Type

Reset

Developer

Reset

User

Reset

Hormonal

Reset

Development Stage

Reset

Potential MPT

Reset

API

Reset
Displaying 71 - 80 of 243
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: GeSea Biosciences, FHI 360, pH Sciences
Project Stage: Pre-clinical
Reference target/product: Eppin
Active Status: Yes
User: Male
Mode: No
Developer: Eppin Pharma, Inc.
Project Stage: Lead Optimization
Alternative Name: Epididymal Peptidase Inhibitor
Reference target/product: EP055
Target
Active Status: Yes
User: Male
Mode: No
Developer: Eppin Pharma, Inc.
Role in reproduction: Sperm Function
Project Stage: Lead Optimization
Alternative Name: Estetrol (E4) + Drospirenone (DRSP) Combined Pill
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Oral
Developer: Mithra
Project Stage: Phase III
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: Hera Health Solutions
Project Stage: Pre-clinical
Alternative Name: Gold T IUD; Novaplus T 380 Ag IUD; Novaplus T 380 Cu IUD; Ancora 375 Ag IUD; Ancora 375 Cu IUD; Ancora 250 Cu Mini IUD
Active Status: Yes
User: Female
Mode: No
Delivery Type: Intrauterine
Developer: Eurogine
Project Stage: Marketed
Alternative Name: EVE-106; EVE106; ethinylestradiol prodrugs
Active Status: Unknown
User: Female
Mode: Yes
Developer: Evestra, Inc.
Project Stage: Pre-clinical
Alternative Name: Etonogestrel (ENG) + Ethinyl Estradiol (EE) Vaginal Ring; EVE112
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Vaginal Ring
Developer: Evestra, Inc., Gedeon Richter Plc.
Project Stage: Phase III
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: Evestra, Inc.
Project Stage: Prototype Development
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: Famy Care Ltd.
Project Stage: Marketed

Pages

CSV